Press Releases
Biological Dynamics, Inc., a leader in exosome technology, today announced that Hoag has joined the growing list of customers adopting Biological Dynamics’ ExoVerita Pro instrument, a cost-efficient, automated exosomal enrichment platform. ExoVerita Pro supports exosome-based research efforts, helping to accelerate early disease detection, determine therapeutic response, and more.
Biological Dynamics, Inc., a leader in exosome-isolation technology for early disease detection, today announced that its ExoLuminate Study is expanding subject enrollment with the addition of four leading institutions in cancer treatment and research: the Dana-Farber Cancer Institute; Moores Cancer Center at UC San Diego Health; University of Florida Health; and MedStar Georgetown.
Media Spotlight
Extracellular vesicles (EVs) are tiny bubbles released by cells containing proteins and genetic material, offering insights into cell health and potential for disease detection. Scientists are exploring ways to customize EVs to deliver therapeutic agents to specific sites, potentially revolutionizing treatment for conditions like cancer and spinal cord injuries.
This interview discusses Biological Dynamics, its technology, and it’s future directions.
Upcoming Events
Visit Biological Dynamics at Booth 10071.
Attend the 2024 ASCO Annual Meeting and be part of the most significant gathering of oncology professionals worldwide, making connections and forging collaborations that can change the landscape of cancer care.